Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP
NewsfeedCancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
Scientists discover gene that stops spread of deadly lung cancer
Lung cancer has a poor survival rate because it often spreads quickly to other parts of the body. Now scientists have discovered a gene that may stop it.
Genes identified that contribute to radiation resistance
A team of researchers from the University of Wisconsin have identified 46 genes in Escherichia coli that are necessary for its survival at exceptionally high levels of radiation.
Intervention strategy in in low-income families helps parents nurture childre...
A new Northwestern University study suggests that an intervention focused on strengthening families can reduce inflammation, a chronic over activation of parts of the immune system that is important...
Novel regulator of the activity of a protein inactive in over 50% of human tu...
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona have discovered the interaction between HERC2 proteins with another protein called p53 that is...
Enzyme lost in 100 percent of kidney tumors analyzed
In an analysis of small molecules called metabolites used by the body to make fuel in normal and cancerous cells in human kidney tissue, a research team from the Perelman School of Medicine at the...
Newsfeed display by CaRP
|Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net|